Mirae Asset Global Investments’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Buy |
2,516
+343
| +16% | +$15K | ﹤0.01% | 1123 |
|
|
2025
Q1 | $64.4K | Buy |
2,173
+15
| +0.7% | +$444 | ﹤0.01% | 1192 |
|
|
2024
Q4 | $86.6K | Sell |
2,158
-178
| -8% | -$7.14K | ﹤0.01% | 1173 |
|
|
2024
Q3 | $114K | Buy |
2,336
+504
| +28% | +$24.5K | ﹤0.01% | 1168 |
|
|
2024
Q2 | $55.4K | Sell |
1,832
-22,639
| -93% | -$684K | ﹤0.01% | 1230 |
|
|
2024
Q1 | $787K | Buy |
24,471
+1,531
| +7% | +$49.3K | ﹤0.01% | 1661 |
|
|
2023
Q4 | $584K | Buy |
22,940
+524
| +2% | +$13.3K | ﹤0.01% | 1888 |
|
|
2023
Q3 | $312K | Sell |
22,416
-2,454
| -10% | -$34.1K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $567K | Sell |
24,870
-698
| -3% | -$15.9K | ﹤0.01% | 1887 |
|
|
2023
Q1 | $758K | Buy |
25,568
+7,894
| +45% | +$234K | ﹤0.01% | 1688 |
|
|
2022
Q4 | $441K | Buy |
17,674
+621
| +4% | +$15.5K | ﹤0.01% | 1960 |
|
|
2022
Q3 | $371K | Buy |
17,053
+6,036
| +55% | +$131K | ﹤0.01% | 2054 |
|
|
2022
Q2 | $217K | Buy |
+11,017
| New | +$217K | ﹤0.01% | 2122 |
|